background image

Paid Clinical Trials Minnesota

Discover 1,867 paid clinical trials in Minnesota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate the Effect of Aficamten in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Recruiting
PHASE2
PHASE3

Sponsor:

Cytokinetics

Location:

Rochester MN, Iowa City IA, Omaha NE, Milwaukee WIshow 18 more

Code:

NCT06412666

Conditions

Pediatric

Symptomatic Obstructive Hypertrophic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Aficamten

Placebo

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Burnsville MN, Hoffman Estates IL, Kansas City MO, Wichita KSshow 41 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension

Recruiting

Sponsor:

Mayo Clinic

Location:

Rochester MN

Code:

NCT06409026

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sotatercept

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Recruiting
PHASE1
PHASE2

Sponsor:

C4 Therapeutics, Inc.

Location:

Rochester MN, Milwaukee WI, Saint Louis MO, Denver COshow 7 more

Code:

NCT04756726

Conditions

Multiple Myeloma

Lymphoma, Non-Hodgkin's

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemsidomide

Dexamethasone Oral

Molecular Epidemiology of Pediatric Germ Cell Tumors

Recruiting

Sponsor:

Children's Oncology Group

Location:

Minneapolis MN

Code:

NCT05564026

Conditions

Germ Cell Tumor

Germinoma

Teratoma

Embryonal Carcinoma

Yolk Sac Tumor

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Questionnaire Administration

Tumor Specimen Collection

Germline DNA Samples

Blood Sample Collection

Tertiary Prevention of Child Sexual Abuse

Recruiting

Sponsor:

University of Minnesota

Location:

Minneapolis MN

Code:

NCT06126926

Conditions

Child Sexual Abuse

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

group therapy

Treatment as usual

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting
PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Rochester MN, Madison WI, Kansas City MO, Saint Louis MOshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Sauk Rapids MN, Roseville MN, Mendota Heights MN, Burnsville MNshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Recruiting

Sponsor:

North Texas Veterans Healthcare System

Location:

Minneapolis MN, Omaha NE, Denver CO, Oklahoma City OKshow 7 more

Code:

NCT02660866

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo + background APT + SMT

Vorapaxar 2.08 mg/d + background APT + SMT.

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Saint Cloud MN, Princeton MN, Monticello MN, Brainerd MNshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Popular cities in Minnesota

Minnesota offers a strong healthcare network and renowned medical research institutions, making it a prominent hub for a wide range of clinical trials. Leading organizations such as the Mayo Clinic, University of Minnesota Medical School, and Hennepin Healthcare are at the forefront of cutting-edge research.

These institutions are recognized globally for their contributions to medical advancements, placing Minnesota as a key player in clinical trials across various medical fields, from cancer and cardiovascular research to neurological and rare diseases.

Why choose Minnesota for clinical trials?

Common conditions studied in Minnesota

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Minnesota